Introduction The COVID pandemic prompted a significant increase in the utilization of
telemedicine (TM) for substance use disorder (SUD) treatment. As we transition towards a …

Purpose of review The goal of this review is to assess the use of digital technologies to
promote the health and well-being of transgender and gender diverse (TGD) people. Recent …

Abstract Background In 2020, 2.8 million people required substance use disorder (SUD)
treatment in nonmetropolitan or 'rural'areas in the US Among this population, only 10 …

Objective The COVID-19 pandemic has transformed care delivery for patients with opioid
use disorder (OUD); however, little is known about the experiences of front-line clinicians in …

Background COVID-19 has exacerbated income inequality, structural racism, and social
isolation—issues that drive addiction and have previously manifested in the epidemic of …

Background Avoiding interruptions and dropout in outpatient care can prevent mental illness
symptom exacerbation and costly crisis services, such as emergency room visits and …

Background: With widespread smartphone ownership, mobile health apps (mHealth) can
expand access to evidence-based interventions for mental health conditions, including …

Objective To examine rural–urban disparities in substance use disorder treatment access
and continuation. Data Sources and Study Setting We analyzed a 2016–2018 US national …

Background The COVID-19 pandemic exacerbated access barriers for patients with opioid
use disorder. Telehealth presents an opportunity to improve access, treatment quality, and …

Background We sought to assess the impact of telemedicine on healthcare utilization and
medical expenditures among patients with a diagnosis of gastrointestinal (GI) cancer …